Terms: = Liver cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
602 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications.
Li J; Zhang L; Ge T; Liu J; Wang C; Yu Q
Drug Des Devel Ther; 2024; 18():829-843. PubMed ID: 38524877
[TBL] [Abstract] [Full Text] [Related]
3. Rebastinib attenuates liver injury following cecal ligation and puncture in male mice.
Zaini A; Jawad HE; Al-Mudhafar DH; Hadi NR
J Med Life; 2023 Nov; 16(11):1678-1684. PubMed ID: 38406786
[TBL] [Abstract] [Full Text] [Related]
4. PD-1 inhibitor combined with albumin paclitaxel and apatinib as second-line treatment for patients with metastatic gastric cancer: a single-center, single-arm, phase II study.
Gou M; Zhang Y; Wang Z; Qian N; Dai G
Invest New Drugs; 2024 Apr; 42(2):171-178. PubMed ID: 38347177
[TBL] [Abstract] [Full Text] [Related]
5. Design, synthesis, and anticancer evaluation of N-sulfonylpiperidines as potential vegfr-2 inhibitors, apoptotic inducers.
Elgammal WE; Halawa AH; Eissa IH; Elkady H; Metwaly AM; Hassan SM; El-Agrody AM
Bioorg Chem; 2024 Apr; 145():107157. PubMed ID: 38340473
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and management of proteinuria associated with vascular endothelial growth factor receptor-targeted tyrosine kinase inhibitor treatment in advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer.
Kato T; Mizuno R; Miyake H
Int J Urol; 2024 May; 31(5):465-474. PubMed ID: 38318663
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
8. Anti-hepatocellular carcinoma activity of Sorbaria sorbifolia by regulating vegfr and c-Met/apoptotic pathway.
Xu ZH; Dang Y; Dong Y; Dong CY; Liu Y; Chen X; Yao Z; Shi JP
J Ethnopharmacol; 2024 Apr; 324():117758. PubMed ID: 38246481
[TBL] [Abstract] [Full Text] [Related]
9. A Synergistic Combination of Oleanolic Acid and Apatinib to Enhance Antitumor Effect on liver cancer Cells and Protect against Hepatic Injury.
Ren J; Yan J; Raza F; Zafar H; Wan H; Chen X; Cui Q; Li H; Wang X
Recent Pat Anticancer Drug Discov; 2024; 19(2):199-208. PubMed ID: 38214359
[TBL] [Abstract] [Full Text] [Related]
10. Anti-cancer activity and cellular uptake of 7,3',4'- and 7,8,4'-trihydroxyisoflavone in HepG2 cells under hypoxic conditions.
Tzeng WS; Teng WL; Huang PH; Yen FL; Shiue YL
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2288806. PubMed ID: 38153119
[TBL] [Abstract] [Full Text] [Related]
11. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
Huang WK; Hsu HC; Yang TS; Lu CW; Pan YR; Wu CE; Chung WH; Hung SI; Yeh CN
Eur J Cancer; 2023 Dec; 195():113286. PubMed ID: 37968194
[TBL] [Abstract] [Full Text] [Related]
12. Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic cancer Angiosuppression.
Hasselluhn MC; Decker-Farrell AR; Vlahos L; Thomas DH; Curiel-Garcia A; Maurer HC; Wasko UN; Tomassoni L; Sastra SA; Palermo CF; Dalton TC; Ma A; Li F; Tolosa EJ; Hibshoosh H; Fernandez-Zapico ME; Muir A; Califano A; Olive KP
Cancer Discov; 2024 Feb; 14(2):348-361. PubMed ID: 37966260
[TBL] [Abstract] [Full Text] [Related]
13. Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
15. Camrelizumab (a PD-1 inhibitor) plus apatinib (an vegfr-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic liver cancer stage C (TRIPLET): a phase II study.
Zhang TQ; Geng ZJ; Zuo MX; Li JB; Huang JH; Huang ZL; Wu PH; Gu YK
Signal Transduct Target Ther; 2023 Oct; 8(1):413. PubMed ID: 37884523
[TBL] [Abstract] [Full Text] [Related]
16. pH-Responsive and Actively Targeted Metal-Organic Framework Structures for Multimodal Antitumor Therapy and Inhibition of Tumor Invasion and Metastasis.
Jia W; Jin B; Xu W; Liu S; Mao X; Peng H; Zhang Y
ACS Appl Mater Interfaces; 2023 Nov; 15(43):50069-50082. PubMed ID: 37871135
[TBL] [Abstract] [Full Text] [Related]
17. Construction and validation of a immune-related prognostic gene DHRS1 in hepatocellular carcinoma based on bioinformatic analysis.
Xu S; Wang W; Meng T; Wang F; Wang G; Huang F; Wang G; Yu X; Wu R; Hou L; Ye Z; Zhang X; Zhao H; Shen Y
Medicine (Baltimore); 2023 Oct; 102(42):e35268. PubMed ID: 37861541
[TBL] [Abstract] [Full Text] [Related]
18. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.
Zhang L; Xu J; Zhou S; Yao F; Zhang R; You W; Dai J; Yu K; Zhang Y; Baheti T; Pu L; Xu J; Qian X; Zhang C; Xia Y; Dai X; Li Q; Wang X
J Hepatol; 2024 Jan; 80(1):82-98. PubMed ID: 37838036
[TBL] [Abstract] [Full Text] [Related]
19. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
[TBL] [Abstract] [Full Text] [Related]
20. In vivo self-assembly and delivery of vegfr2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy.
Yu L; Fan G; Wang Q; Zhu Y; Zhu H; Chang J; Wang Z; Zhan S; Hua X; She D; Huang J; Wang Y; Zhao J; Zhang CY; Chen X; Zhou G
Cell Death Dis; 2023 Sep; 14(9):626. PubMed ID: 37739958
[TBL] [Abstract] [Full Text] [Related]
[Next]
